Home›Search›Cancer Gene Therapy

Cancer Gene Therapy

Springer Nature · United States · Est. 1992

ISSN1476-5500

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

184

days submission → published

measured · last 17 articles · accept 159d

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.749

H-Indexi

111

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.961

Total Worksi

2,971

Total Citationsi

89,422

2yr Mean Citednessi

6.13

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1992

FrequencyTwelve No. A Year, 2000-

StatusActive (last: 2026)

Total Publications2,971

Publisher OrgSpringer Nature

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

7/12 · 58%

✅

Do you know the journal / publisher?

Springer Nature

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1476-5500

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2.7k

2019

111

4.3k

2020

137

2021

170

2022

140

2023

146

1.8k

2024

132

382

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Molecular BiologyQ1

Molecular MedicineQ1

Cancer ResearchQ2

Subject Classification

Web of Science Categories

Biotechnology & Applied MicrobiologyGenetics & HeredityMedicine, Research & ExperimentalOncology

Scopus Categories

Cancer ResearchMolecular MedicineMolecular Biology

Research Topics (OpenAlex)

Virus-based gene therapy researchRNA Interference and Gene DeliveryCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer Research and TreatmentsCancer-related molecular mechanisms researchMicroRNA in disease regulationRNA modifications and cancerViral Infectious Diseases and Gene Expression in InsectsImmune Cell Function and Interaction

Frequently asked questions about Cancer Gene Therapy

Is Cancer Gene Therapy a predatory journal?

PubScope has no integrity flags on record for Cancer Gene Therapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Gene Therapy?

Cancer Gene Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.13.

Is Cancer Gene Therapy indexed in Scopus and Web of Science?

Cancer Gene Therapy is indexed in Web of Science, Scopus.